✦ LIBER ✦

PCN11 GEFITINIB COMPARED WITH DOUBLET CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC): A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON

✍ Scribed by SJ Edwards; N Welton; J Borrill

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN1 TOLERABILITY OF FIRST-LINE TREATMEN

✍ SJ Edwards; N Welton; J Borrill 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PCN100 COST-EFFECTIVENESS OF GEFITINIB V

✍ J Jacob; M Henriksson; D Brattström 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Gefitinib Compared with Systemic Chemoth

✍ F. Wang; L.D. Wang; B. Li; Z.X. Sheng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 835 KB

Optimal duration of first-line chemother

✍ João Paulo da Silveira Nogueira Lima; Lucas Vieira dos Santos; Emma Chen Sasse; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 410 KB

Doublet Versus Single Cytotoxic Agent as

✍ Qi, Wei-Xiang; Tang, Li-na; He, Ai-na; Shen, Zan; Lin, Feng; Yao, Yang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 465 KB

PCN63 EPIDERMAL GROWTH FACTOR RECEPTOR (

✍ G. de Lima Lopes 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB